AU5695294A - Monoclonal antibodies against a carbohydrate-dependent epitope related to the V2 region of HIV-1 GP120 - Google Patents

Monoclonal antibodies against a carbohydrate-dependent epitope related to the V2 region of HIV-1 GP120

Info

Publication number
AU5695294A
AU5695294A AU56952/94A AU5695294A AU5695294A AU 5695294 A AU5695294 A AU 5695294A AU 56952/94 A AU56952/94 A AU 56952/94A AU 5695294 A AU5695294 A AU 5695294A AU 5695294 A AU5695294 A AU 5695294A
Authority
AU
Australia
Prior art keywords
hiv
carbohydrate
region
monoclonal antibodies
antibodies against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56952/94A
Inventor
Abraham Pinter
Shermaine Tilley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Public Health Research Institute of City of New York Inc
Original Assignee
NEW YORK HEALTH RES INST
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NEW YORK HEALTH RES INST filed Critical NEW YORK HEALTH RES INST
Publication of AU5695294A publication Critical patent/AU5695294A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036Retroviridae, e.g. leukemia viruses
    • C07K16/1045Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU56952/94A 1992-03-31 1993-03-31 Monoclonal antibodies against a carbohydrate-dependent epitope related to the V2 region of HIV-1 GP120 Abandoned AU5695294A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86088992A 1992-03-31 1992-03-31
US860889 1992-03-31
PCT/US1993/003044 WO1993020104A1 (en) 1992-03-31 1993-03-31 Monoclonal antibodies against a carbohydrate-dependent epitope related to the v2 region of hiv-1 gp120

Publications (1)

Publication Number Publication Date
AU5695294A true AU5695294A (en) 1994-03-15

Family

ID=25334289

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56952/94A Abandoned AU5695294A (en) 1992-03-31 1993-03-31 Monoclonal antibodies against a carbohydrate-dependent epitope related to the V2 region of HIV-1 GP120

Country Status (2)

Country Link
AU (1) AU5695294A (en)
WO (1) WO1993020104A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69111440T2 (en) * 1990-04-03 1996-03-28 Genentech Inc METHODS AND COMPOSITIONS FOR Vaccination Against HIV.
US7041293B1 (en) 1990-04-03 2006-05-09 Genentech, Inc. HIV env antibodies
AU700371B2 (en) 1993-06-07 1999-01-07 Genentech Inc. Hiv envelope polypeptides
US6585979B1 (en) 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition

Also Published As

Publication number Publication date
WO1993020104A1 (en) 1993-10-14

Similar Documents

Publication Publication Date Title
HUT66445A (en) Monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120
AU4985496A (en) Administration of a cyclosporine-specific monoclonal antibody that cross-reacts with hiv-1 p24 gag to treat hiv infection
AU2981992A (en) Expression of specific immunogens using viral antigens
EP0777497A4 (en) Human neutralizing monoclonal antibodies to human immunodeficiency virus
HU896763D0 (en) Process for the preparation of bispecific monoclonal antibody
CA2081150A1 (en) Use of antibody-containing preparations for immunosuppression
AU4618193A (en) Humanized antibodies
ZA884651B (en) Monoclonal antibody specific to hiv antigens
AU6080794A (en) Antibodies directed against binding-associated epitopes
AU3459593A (en) Humanised antibody against hepatitis
AU2784792A (en) Human monoclonal antibodies to the cd4-binding domain of hiv, uses thereof and synergistic neutralization of hiv
AU7203194A (en) Bispecific human monoclonal antibodies specific for human immunodeficiency virus
AU3330689A (en) Monoclonal antibodies
AU7160691A (en) Monoclonal antibodies which neutralize hiv-1 infection and their anti-idiotypes
AU5695294A (en) Monoclonal antibodies against a carbohydrate-dependent epitope related to the V2 region of HIV-1 GP120
IL94624A0 (en) Human monoclonal antibodies to hiv-1 mn qq120
AU2370592A (en) Epitopes of the env protein of the hepatitis c virus
EP0511300A4 (en) Monoclonal antibody specific for non-immunodominant epitope of hiv proteins
AU4959193A (en) High affinity, strongly neutralizing monoclonal antibodies against the CD-4 binding site of GP120 of human immunodeficiency virus
HU9501328D0 (en) Production of human monoclonal antibodies active against hepatitis b surface antigen
AU7184191A (en) Sperm antigen corresponding to a sperm autoantigenic epitope and methods of using the same
AU680836B2 (en) Human monoclonal antibodies to human immunodeficiency virus
AU8268491A (en) Phosphonopyrrolidine- and piperidine-containing pseudopeptides of the statin type, a process for their preparation and their use as medicaments against retroviruses
AU1820692A (en) Novel anti-hiv antibodies
GB2279076B (en) Antibodies to fungal antigens